Zavanone C, Panebianco M, Yger M, Borden A, Restivo D, Angelini C, Pavone A, Grimod G, Rosso C, Dupont S
UPMC Paris 6, centre de recherche de l'Institut du cerveau et de la moelle epinière, Inserm 1127, CNRS S_975, ARAMIS, 75013 Paris, France; Neurorehabilitation Unit, hôpital Pitié-Salpêtrière, AP-HP, 75013 Paris, France.
Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom; Department of Internal Medicine, Neurologic Unit, Garibaldi Hospital, Catania, Italy.
Rev Neurol (Paris). 2017 Apr;173(4):189-193. doi: 10.1016/j.neurol.2016.11.004. Epub 2016 Dec 27.
High altitude may be a factor associated with cerebral venous thrombosis (CVT). As our knowledge of CVT at high altitude is limited, it was decided to pool such information from the available case studies to determine whether high altitude can predispose to CVT.
A systematic review of the literature was performed for cases reporting CVT at high altitude. Searches of the PubMed database (up to July 2016) were performed for publications, using 'cerebral venous thrombosis' and 'high altitude' as keywords. Cross-referencing was also done to complete the search.
Ultimately, 13 articles were included in our systematic review. The population consisted of 17 patients, predominately male (14/17), with a mean age of 32 (range: 19-47) years. Altitude range was 3000-8200m. Nine patients stayed at high altitude for>2 weeks; the duration of high altitude stay was unknown for the remainder. A hypercoagulable state was found in nine patients: secondary polycythemia in five; protein C deficiency in one; protein S deficiency in one; and factor V Leiden mutations in two. No comorbidities were found in any of these patients.
Long-term stays at high altitude in association with a hypercoagulable state - in particular, congenital or acquired thrombophilia - appears to predispose to CVT. The association of CVT with a single exposure to high altitude seems low, but the risk cannot as yet be specifically estimated.
高海拔可能是与脑静脉血栓形成(CVT)相关的一个因素。由于我们对高海拔地区CVT的了解有限,因此决定汇总现有病例研究中的此类信息,以确定高海拔是否易引发CVT。
对报告高海拔地区CVT的病例进行了文献系统综述。使用“脑静脉血栓形成”和“高海拔”作为关键词,在PubMed数据库(截至2016年7月)中搜索相关出版物。还进行了交叉引用以完成搜索。
最终,13篇文章纳入了我们的系统综述。研究对象包括17例患者,以男性为主(14/17),平均年龄32岁(范围:19 - 47岁)。海拔范围为3000 - 8200米。9例患者在高海拔地区停留超过2周;其余患者的高海拔停留时间未知。9例患者存在高凝状态:5例为继发性红细胞增多症;1例为蛋白C缺乏;1例为蛋白S缺乏;2例为因子V莱顿突变。这些患者均未发现合并症。
长期处于高海拔并伴有高凝状态——尤其是先天性或获得性血栓形成倾向——似乎易引发CVT。CVT与单次暴露于高海拔的关联似乎较低,但目前尚无法具体估计该风险。